Secukinumab Associated Choroidal Neovascularization
<p>A previously healthy 38-year-old woman with non-radiographic spondyloarthritis (nrSpA) developed juxta-foveal Choroidal Neovascularization (CNV) in the right eye three months after starting treatment with the anti-IL-17A inhibitor secukinumab. As there was no sign of ocular inflammation, no...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Journal of Clinical Research and Ophthalmology - Peertechz Publications,
2022-03-09.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|